United Therapeutics Shares Outstanding 2006-2018 | UTHR

United Therapeutics shares outstanding from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
United Therapeutics Annual Shares Outstanding
(Millions of Shares)
2018 44
2017 45
2016 47
2015 51
2014 54
2013 53
2012 53
2011 59
2010 60
2009 56
2008 46
2007 45
2006 48
2005 50
United Therapeutics Quarterly Shares Outstanding
(Millions of Shares)
Q4 2018 44
Q3 2018 44
Q2 2018 43
Q1 2018 44
Q4 2017 45
Q3 2017 44
Q2 2017 45
Q1 2017 46
Q4 2016 47
Q3 2016 46
Q2 2016 47
Q1 2016 49
Q4 2015 51
Q3 2015 50
Q2 2015 52
Q1 2015 47
Q4 2014 54
Q3 2014 47
Q2 2014 53
Q1 2014 57
Q4 2013 53
Q3 2013 54
Q2 2013 53
Q1 2013 52
Q4 2012 53
Q3 2012 54
Q2 2012 54
Q1 2012 55
Q4 2011 59
Q3 2011 61
Q2 2011 63
Q1 2011 63
Q4 2010 60
Q3 2010 60
Q2 2010 60
Q1 2010 60
Q4 2009 56
Q3 2009 58
Q2 2009 53
Q1 2009 54
Q4 2008 46
Q3 2008 51
Q2 2008 49
Q1 2008 48
Q4 2007 45
Q3 2007 45
Q2 2007 44
Q1 2007 43
Q4 2006 48
Q3 2006 50
Q2 2006 51
Q1 2006 51
Q4 2005 50
Q3 2005 51
Q2 2005 50
Q1 2005 49
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $4.387B $1.628B
United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening conditions. United Therapeutics (UT) has an overarching commitment to environmental sustainability. The company's product candidates include Adcirca is a phosphodiesterase 5 (PDE-5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH)(WHO Group 1) to improve exercise ability in PAH patients. Orenitram is a prostacyclin vasodilator indicated for treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise capacity. Remodulin is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) to diminish symptoms associated with exercise. Tyvaso is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $47.457B 31.54
Takeda Pharmaceutical (TAK) Japan $28.357B 10.49
Grifols (GRFS) Spain $12.830B 15.68
Ionis Pharmaceuticals (IONS) United States $10.102B 32.30
Sage Therapeutics (SAGE) United States $7.758B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.328B 10.49
Neurocrine Biosciences (NBIX) United States $7.158B 461.35
Catalent (CTLT) United States $6.403B 26.81
Nektar Therapeutics (NKTR) United States $5.516B 8.80
Tilray (TLRY) United States $4.740B 0.00
Taro Pharmaceutical Industries (TARO) Israel $4.097B 13.19
FibroGen (FGEN) United States $4.039B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.793B 0.00
Portola Pharmaceuticals (PTLA) United States $2.252B 0.00
PTC Therapeutics (PTCT) United States $2.099B 0.00
USANA Health Sciences (USNA) United States $1.921B 16.12
Heron Therapeutics (HRTX) United States $1.837B 0.00
Aerie Pharmaceuticals (AERI) United States $1.799B 0.00
Xencor (XNCR) United States $1.765B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.738B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.712B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.668B 20.77
Madrigal Pharmaceuticals (MDGL) United States $1.627B 0.00
Endo (ENDP) Ireland $1.598B 2.46
Zogenix (ZGNX) United States $1.534B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.518B 131.46
Corcept Therapeutics (CORT) United States $1.372B 19.93
Tricida (TCDA) United States $1.330B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.279B 0.00
Esperion Therapeutics (ESPR) United States $1.098B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.066B 0.00
TherapeuticsMD (TXMD) United States $1.020B 0.00
Radius Health (RDUS) United States $0.980B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.873B 0.00
Akebia Therapeutics (AKBA) United States $0.786B 0.00
CannTrust Holdings (CTST) Canada $0.751B 0.00
ArQule (ARQL) United States $0.713B 0.00
ChemoCentryx (CCXI) United States $0.700B 0.00
Dermira (DERM) United States $0.619B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.577B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.573B 0.00
Odonate Therapeutics (ODT) United States $0.573B 0.00
Forty Seven (FTSV) United States $0.559B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.546B 0.00
GlycoMimetics (GLYC) United States $0.523B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.460B 23.76
Corbus Pharmaceuticals Holdings (CRBP) United States $0.454B 0.00
Translate Bio (TBIO) United States $0.452B 0.00
Collegium Pharmaceutical (COLL) United States $0.451B 0.00
KalVista Pharmaceuticals (KALV) United States $0.440B 0.00
TCR2 THERAPTCS (TCRR) United States $0.439B 0.00
Siga Technologies (SIGA) United States $0.430B 0.00
OptiNose (OPTN) United States $0.408B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.396B 0.00
Flexion Therapeutics (FLXN) United States $0.388B 0.00
Aptorum Group (APM) China $0.388B 0.00
ImmunoGen (IMGN) United States $0.368B 0.00
Mast Therapeutics (SVRA) United States $0.334B 0.00
Harpoon Therapy (HARP) United States $0.317B 0.00
CASI Pharmaceuticals (CASI) United States $0.316B 0.00
Karyopharm Therapeutics (KPTI) United States $0.282B 0.00
Lannett Co Inc (LCI) United States $0.281B 2.61
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.276B 10.21
Minerva Neurosciences (NERV) United States $0.274B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.274B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.266B 0.00
Xeris Pharmaceuticals (XERS) United States $0.259B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.251B 0.00
Calithera Biosciences (CALA) United States $0.241B 0.00
Dova Pharmaceuticals (DOVA) United States $0.233B 0.00
Molecular Templates (MTEM) United States $0.231B 0.00
Aclaris Therapeutics (ACRS) United States $0.228B 0.00
Concert Pharmaceuticals (CNCE) United States $0.222B 0.00
Ardelyx (ARDX) United States $0.212B 0.00
Affimed (AFMD) Germany $0.209B 0.00
MEI Pharma (MEIP) United States $0.208B 0.00
Aldeyra Therapeutics (ALDX) United States $0.204B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.201B 0.00
Opexa Therapeutics (ACER) United States $0.200B 0.00
Galectin Therapeutics (GALT) United States $0.196B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.194B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.186B 0.00
Recro Pharma (REPH) United States $0.184B 0.00
Jounce Therapeutics (JNCE) United States $0.184B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.183B 0.00
Nature's Sunshine Products (NATR) United States $0.182B 189.00
ElectroCore (ECOR) United States $0.182B 0.00
Neon Therapeutics (NTGN) United States $0.177B 0.00
Majesco Entertainment (PTE) United States $0.174B 0.00
Redhill Biopharma (RDHL) Israel $0.172B 0.00
Aratana Therapeutics (PETX) United States $0.171B 0.00
IMV INC (IMV) Canada $0.170B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.168B 0.00
Tyme Technologies (TYME) United States $0.158B 0.00
Aquestive Therapeutics (AQST) United States $0.157B 0.00
Ocular Therapeutix (OCUL) United States $0.156B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.136B 0.00
MediWound (MDWD) Israel $0.132B 0.00
China SXT Pharmaceuticals (SXTC) China $0.119B 0.00
Iterum Therapeutics (ITRM) Ireland $0.114B 0.00
ProNAi Therapeutics (SRRA) Canada $0.109B 0.00
Cardiome Pharma (CORV) Canada $0.106B 0.00
Nivalis Therapeutics (ALPN) United States $0.105B 0.00
Natural Alternatives (NAII) United States $0.098B 9.62
Neos Therapeutics (NEOS) United States $0.097B 0.00
Zafgen (ZFGN) United States $0.097B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.094B 0.00
Adherex Technologies (FENC) United States $0.094B 0.00
DURECT (DRRX) United States $0.093B 0.00
Champions Oncology (CSBR) United States $0.092B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.091B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.090B 0.00
Infinity Pharmaceuticals (INFI) United States $0.089B 0.00
Bio Blast Pharma (ENLV) Israel $0.083B 0.00
SCYNEXIS (SCYX) United States $0.083B 0.00
Otonomy (OTIC) United States $0.079B 0.00
Genocea Biosciences (GNCA) United States $0.078B 0.00
Avenue Therapeutics (ATXI) United States $0.075B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.072B 0.00
Capnia (SLNO) United States $0.064B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.057B 0.00
CTI BioPharma (CTIC) United States $0.056B 0.00
Forward Pharma (FWP) Denmark $0.056B 0.00
Melinta Therapeutics (MLNT) United States $0.049B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.048B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.048B 0.00
Bio-Path Holdings (BPTH) United States $0.048B 0.00
Lipocine (LPCN) United States $0.044B 0.00
KemPharm (KMPH) United States $0.043B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.043B 0.00
ContraFect (CFRX) United States $0.042B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.040B 0.00
BioLineRx (BLRX) Israel $0.040B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
Heat Biologics (HTBX) United States $0.038B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
HANCOCK JAFFE (HJLI) United States $0.034B 0.00
Shineco (TYHT) China $0.029B 4.88
Summit Therapeutics (SMMT) United Kingdom $0.026B 3.47
PharmAthene (ALT) United States $0.025B 0.00
Citius Pharmaceuticals (CTXR) United States $0.024B 0.00
Jaguar Animal Health (JAGX) United States $0.024B 0.00
Achieve Life Sciences (ACHV) United States $0.024B 0.00
Biomerica (BMRA) United States $0.024B 0.00
Onconova Therapeutics (ONTX) United States $0.022B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.020B 0.00
NOVAN INC (NOVN) United States $0.020B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
Pain Therapeutics (SAVA) United States $0.019B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.017B 0.00
Xenetic Biosciences (XBIO) United States $0.016B 0.00
ESSA Pharma (EPIX) Canada $0.015B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 4.07
Regulus Therapeutics (RGLS) United States $0.012B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.012B 0.00
Achaogen (AKAO) United States $0.011B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.010B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.009B 0.00
Trillium Therapeutics (TRIL) Canada $0.009B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.008B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.006B 0.00
VAXART, INC (VXRT) United States $0.006B 0.00
Midatech Pharma (MTP) United Kingdom $0.006B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00